235 related articles for article (PubMed ID: 22915806)
1. A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.
Lei X; Zhu Y; Jones T; Bai Z; Huang Y; Gao SJ
J Virol; 2012 Nov; 86(21):11698-711. PubMed ID: 22915806
[TBL] [Abstract][Full Text] [Related]
2. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
3. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5.
Liu Y; Sun R; Lin X; Liang D; Deng Q; Lan K
J Virol; 2012 Feb; 86(3):1372-81. PubMed ID: 22013049
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.
Yan Q; Ma X; Shen C; Cao X; Feng N; Qin D; Zeng Y; Zhu J; Gao SJ; Lu C
J Virol; 2014 May; 88(9):4987-5000. PubMed ID: 24554664
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.
Choi HS; Jain V; Krueger B; Marshall V; Kim CH; Shisler JL; Whitby D; Renne R
PLoS Pathog; 2015; 11(11):e1005255. PubMed ID: 26545119
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
[TBL] [Abstract][Full Text] [Related]
8. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.
Abend JR; Ramalingam D; Kieffer-Kwon P; Uldrick TS; Yarchoan R; Ziegelbauer JM
J Virol; 2012 Nov; 86(21):11663-74. PubMed ID: 22896623
[TBL] [Abstract][Full Text] [Related]
10. Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression.
Abend JR; Uldrick T; Ziegelbauer JM
J Virol; 2010 Dec; 84(23):12139-51. PubMed ID: 20844036
[TBL] [Abstract][Full Text] [Related]
11. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.
Li W; Jia X; Shen C; Zhang M; Xu J; Shang Y; Zhu K; Hu M; Yan Q; Qin D; Lee MS; Zhu J; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C
Oncotarget; 2016 May; 7(22):32286-305. PubMed ID: 27058419
[TBL] [Abstract][Full Text] [Related]
12. A Kaposi's sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice.
Boss IW; Nadeau PE; Abbott JR; Yang Y; Mergia A; Renne R
J Virol; 2011 Oct; 85(19):9877-86. PubMed ID: 21813606
[TBL] [Abstract][Full Text] [Related]
13. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
[TBL] [Abstract][Full Text] [Related]
14. Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.
Gottwein E; Corcoran DL; Mukherjee N; Skalsky RL; Hafner M; Nusbaum JD; Shamulailatpam P; Love CL; Dave SS; Tuschl T; Ohler U; Cullen BR
Cell Host Microbe; 2011 Nov; 10(5):515-26. PubMed ID: 22100165
[TBL] [Abstract][Full Text] [Related]
15. Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.
Lei X; Bai Z; Ye F; Xie J; Kim CG; Huang Y; Gao SJ
Nat Cell Biol; 2010 Feb; 12(2):193-9. PubMed ID: 20081837
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus downregulates transforming growth factor β2 to promote enhanced stability of capillary-like tube formation.
DiMaio TA; Gutierrez KD; Lagunoff M
J Virol; 2014 Dec; 88(24):14301-9. PubMed ID: 25275137
[TBL] [Abstract][Full Text] [Related]
19. Viral oncomiR spreading between B and T cells is employed by Kaposi's sarcoma herpesvirus to induce non-cell-autonomous target gene regulation.
Rainy N; Zayoud M; Kloog Y; Rechavi O; Goldstein I
Oncotarget; 2016 Jul; 7(27):41870-41884. PubMed ID: 27248822
[TBL] [Abstract][Full Text] [Related]
20. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
